# EDGAR Filing Document

**Accession Number:** 0000910267
**File Stem:** 9999999995-25-003277
**Filing Date:** 2025-11
**Character Count:** 1384
**Document Hash:** 444da50ab5f16d87c9e0c7f11319cac5
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**9999999995-25-003277.hdr.sgml**: 20251117

**ACCESSION NUMBER**: 9999999995-25-003277

**CONFORMED SUBMISSION TYPE**: EFFECT

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20251114

**DATE AS OF CHANGE**: 20251117

**EFFECTIVENESS DATE**: 20251114

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** TITAN PHARMACEUTICALS INC
- **CENTRAL INDEX KEY:** 0000910267
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 943171940
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** EFFECT
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-230742
- **FILM NUMBER:** 251489147

**BUSINESS ADDRESS:**
- **STREET 1:** 400 OYSTER POINT BLVD
- **STREET 2:** SUITE 505
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94080
- **BUSINESS PHONE:** 6502444990

**MAIL ADDRESS:**
- **STREET 1:** 400 OYSTER POINT BLVD
- **STREET 2:** SUITE 505
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94080

### UNITED STATES
### SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## Notice of Effectiveness

**Date:** November 14, 2025

**Accession Number:** 0001829126-25-007997

**Form Type:** POS AM

---

**CIK:** 0000910267

**Company Name:** TITAN PHARMACEUTICALS INC

**File Number:** 333-230742